FDA MedWatch - Monthly Safety Labeling Changes

The U.S. Food and Drug Administration (FDA) has released the April 2012 Safety Labeling Changes for 43 products, including a number of endocrine related drugs.  These labeling changes affect the boxed warnings, contraindications, warnings, precautions, adverse reactions and/or patient package insert.  A list of the drug names and safety labeling sections revised can be reviewed by clicking here.


AACE Clinical Practice Guidelines are systematically developed, evidence-based documents that assist practitioners about appropriate health care decisions

AACE Position Statements

AACE's Position Statements meet rigorous criteria before being published and utilized and serve as one of the worlds' most trusted sources


AACE continually strives to bring to the world definitive protocols, guidelines and discoveries which further and enhance the greater medical health of the general public.

Find an Endocrinologist

Find an Endocrinologist in your area by entering a ZIP code, or your city and state using our search feature.